In patients with inborn errors of immunity who are prone to viral infections, immunoglobulin replacement therapy (IRT) administered via the conventional subcutaneous route showed lower viral infection ...

Differences in manufacturing processes impact the tolerability of intravenous immune globulin (IVIG) products GC Biopharma's manufacturing process ...

In Japan alone, around 4,000 individuals have a CIDP diagnosis. Sanofi neurology development global head Erik Wallstroem ...

A YOUNG man faced the terrifying risk of internal bleeding after taking a ‘Viagra’ pill bought from a petrol station. The ...

It is the only ready-to-use liquid immunoglobulin therapy with (IgA) content and is set for commercialization in 2026.

Prince Edward Island's Chief Public Health Office says a total of 15 people have now been identified as at risk after ...

A team of physicians recently reported the successful treatment of refractory autoimmune neuropathies through the infusion of ...

Gammagard Liquid ERC is a ready-to-use formulation with low IgA content designed to ease administration burden by removing the need to reconstitute.

The approval of GAMMAGARD LIQUID ERC reinforces our commitment to supporting individualized treatment approaches for people with primary immunodeficiency, including a therapeutic option that has the ...

The province's Chief Public Health Office has identified between four and eight infants who require medication to protect ...

Bharat Serums and Vaccines has received approval from the Subject Expert Committee (SEC) functional under the Central Drugs ...